Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features

被引:0
作者
Shuya Matsubara
Akira Saito
Naoto Tokuyama
Ryu Muraoka
Takeshi Hashimoto
Naoya Satake
Toshitaka Nagao
Masahiko Kuroda
Yoshio Ohno
机构
[1] Tokyo Medical University Hospital,Department of Urology
[2] Tokyo Medical University,Department of AI Applied Quantitative Clinical Science
[3] Tokyo Medical University,Department of Molecular Pathology
[4] Tokyo Medical University,Department of Anatomic Pathology
来源
Scientific Reports | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The recurrence of non-metastatic renal cell carcinoma (RCC) may occur early or late after surgery. This study aimed to develop a recurrence prediction machine learning model based on quantitative nuclear morphologic features of clear cell RCC (ccRCC). We investigated 131 ccRCC patients who underwent nephrectomy (T1-3N0M0). Forty had recurrence within 5 years and 22 between 5 and 10 years; thirty-seven were recurrence-free during 5–10 years and 32 were for more than 10 years. We extracted nuclear features from regions of interest (ROIs) using a digital pathology technique and used them to train 5- and 10-year Support Vector Machine models for recurrence prediction. The models predicted recurrence at 5/10 years after surgery with accuracies of 86.4%/74.1% for each ROI and 100%/100% for each case, respectively. By combining the two models, the accuracy of the recurrence prediction within 5 years was 100%. However, recurrence between 5 and 10 years was correctly predicted for only 5 of the 12 test cases. The machine learning models showed good accuracy for recurrence prediction within 5 years after surgery and may be useful for the design of follow-up protocols and patient selection for adjuvant therapy.
引用
收藏
相关论文
共 29 条
[1]  
Egger SE(2006)Renal cell carcinoma recurrence after nephrectomy for localized disease: Predicting from time of recurrence J. Clin. Oncol. 24 3101-3106
[2]  
Richards KA(2016)Surveillance following surgery for nonmetastatic renal cell carcinoma Curr. Opin. Urol. 26 432-438
[3]  
Abel EJ(2021)Renal mass and localized renal cancer: Evaluation, management, and follow-up: AUA guideline J. Urol. 206 209-218
[4]  
Campbell SC(2003)Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: A stratification tool for prospective clinical trials Cancer 97 1663-1671
[5]  
Leibovich BC(2001)Improved prognostication of renal cell carcinoma using an integraded staging system J. Clin. Oncol. 19 1649-1657
[6]  
Zisman A(2022)Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features Mod. Pathol. 35 533-538
[7]  
Tokuyama N(2021)Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning Mod. Pathol. 34 417-425
[8]  
Saito A(2020)Computerized image analysis of tumor cell nuclear morphology can improve patient selection for clinical trials in localized clear cell renal cell carcinoma J. Pathol. Inform. 11 35-417
[9]  
Um IH(2012)Follow-up of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma J. Urol. 187 411-116.e1
[10]  
Ohno Y(2020)Female gender predicts favorable prognosis in patients with non-metastatic clear cell renal cell carcinoma undergoing curative surgery: Results from the International Marker Consortium for Renal Cancer (INMARC) Clin. Genitourin. Cancer 18 111-2467